Published by Josh White on 9th August 2022
(Sharecast News) - Biopharmaceutical developer Arecor Therapeutics has been granted two European patents protecting its novel formulations of high-concentration 'adalimumab' until 2038, it announced on Tuesday.
URL: http://www.digitallook.com/dl/news/story/32880421/...